Sensorion SA - ESG Rating & Company Profile powered by AI
Browse to the bottom of this webpage for potential risks for Sensorion SA based on sector, geography and size. This page is a zero-cost ESG report covering Sensorion SA. The report of Sensorion SA incorporates intelligence from across the web and also from public filings by Sensorion SA.
Sensorion SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.0; made up of an environmental score of 5.3, social score of 1.6 and governance score of 2.0.
3.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1309 | Willow Biosciences Inc | 3.1 | Medium |
1309 | biOasis Technologies Inc | 3.1 | Medium |
1336 | Sensorion SA | 3.0 | Medium |
1336 | BridgeBio Pharma Inc | 3.0 | Medium |
1336 | Absci Corp | 3.0 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Sensorion SA have an accelerator or VC vehicle to help deliver innovation?
Does Sensorion SA disclose current and historical energy intensity?
Does Sensorion SA report the average age of the workforce?
Does Sensorion SA reference operational or capital allocation in relation to climate change?
Does Sensorion SA disclose its ethnicity pay gap?
Does Sensorion SA disclose cybersecurity risks?
Does Sensorion SA offer flexible work?
Does Sensorion SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Sensorion SA disclose the number of employees in R&D functions?
Does Sensorion SA conduct supply chain audits?
Does Sensorion SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Sensorion SA conduct 360 degree staff reviews?
Does Sensorion SA disclose the individual responsible for D&I?
Does Sensorion SA disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Sensorion SA disclose current and / or historical scope 2 emissions?
Does Sensorion SA disclose water use targets?
Does Sensorion SA have careers partnerships with academic institutions?
Did Sensorion SA have a product recall in the last two years?
Does Sensorion SA disclose incidents of discrimination?
Does Sensorion SA allow for Work Councils/Collective Agreements to be formed?
Has Sensorion SA issued a profit warning in the past 24 months?
Does Sensorion SA disclose parental leave metrics?
Does Sensorion SA disclose climate scenario or pathway analysis?
Does Sensorion SA disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Sensorion SA disclose the pay ratio of women to men?
Does Sensorion SA support suppliers with sustainability related research and development?
Does Sensorion SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Sensorion SA reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Sensorion SA involved in embryonic stem cell research?
Does Sensorion SA disclose GHG and Air Emissions intensity?
Does Sensorion SA disclose its waste policy?
Does Sensorion SA report according to TCFD requirements?
Does Sensorion SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Sensorion SA disclose energy use targets?
Does Sensorion SA disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Sensorion SA have a policy relating to cyber security?
Have a different question?
Potential Risks for Sensorion SA
These potential risks are based on the size, segment and geographies of the company.
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.